Enzalutamide Data to Be Presented at ASCO GU Symposium
[at noodls] – SAN FRANCISCO, CA and TOKYO — (Marketwire) — 01/30/13 — Medivation, Inc. (NASDAQ: MDVN) and Astellas Pharma Inc. (TSE: 4503) today announced that six abstracts related to enzalutamide research will … more
View todays social media effects on MDVN
View the latest stocks trending across Twitter. Click to view dashboard